Collaborative Translational Infectious Disease Research to Accelerate Integrated Health Care Solutions

The Surveillance Evaluation and Research Program within Kirby Institute are world leaders in translational infectious disease research across the Asia-Pacific. With expertise in basic science, clinical and behavioural research, population-health, health economics and systems, modelling, biostatistics and epidemiology, this program conduct collaborative research to provide integrated health care solutions for all.

Competitive advantage

  • Extensive experience in clinical trials, diagnostic and implementation research
  • Established clinical and surveillance networks across the Asia-Pacific
  • Integrated framework for effective transdisciplinary infectious disease research
  • Trusted and collaborative partnerships with community, decision makers, industry, academic, not-for-profit organisations, regulatory bodies, government and ministries of health
  • Well characterised cohorts and linked data to model the scale, health-economic impact and real-world market potential of new biomedical technologies

Impact

  • Sustainable scale-up of novel behavioural and biomedical interventions strategies
  • Transformational improvements in health outcomes of affected communities globally

Successful outcomes

  • Demonstration of impact of novel point-of-care diagnostic technologies for infections including chlamydia, gonorrhoea, human papilloma virus, hepatitis C virus and HIV infection among remote and marginalised communities

Capabilities and facilities

  • Transdisciplinary field research
  • Rapid and sustainable integration of biomedical interventions into health systems
  • Field evaluation and implementat
Tags
lensBiomolecular Innovations
lensBio-engineering for a Healthy Future